Durect Corp (DRRX)
0.855
+0.04
(+4.77%)
USD |
NASDAQ |
Apr 24, 13:09
Durect Price to Book Value: 1.795 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.713 |
| April 22, 2024 | 1.69 |
| April 19, 2024 | 1.829 |
| April 18, 2024 | 1.910 |
| April 17, 2024 | 1.843 |
| April 16, 2024 | 1.641 |
| April 15, 2024 | 1.670 |
| April 12, 2024 | 1.608 |
| April 11, 2024 | 1.722 |
| April 10, 2024 | 1.756 |
| April 09, 2024 | 1.774 |
| April 08, 2024 | 1.890 |
| April 05, 2024 | 1.956 |
| April 04, 2024 | 2.162 |
| April 03, 2024 | 2.414 |
| April 02, 2024 | 2.225 |
| April 01, 2024 | 2.330 |
| March 28, 2024 | 2.540 |
| March 27, 2024 | 2.813 |
| March 26, 2024 | 2.666 |
| March 25, 2024 | 2.626 |
| March 22, 2024 | 2.401 |
| March 21, 2024 | 2.565 |
| March 20, 2024 | 2.626 |
| March 19, 2024 | 2.421 |
| Date | Value |
|---|---|
| March 18, 2024 | 2.770 |
| March 15, 2024 | 2.647 |
| March 14, 2024 | 2.811 |
| March 13, 2024 | 2.319 |
| March 12, 2024 | 2.360 |
| March 11, 2024 | 2.072 |
| March 08, 2024 | 2.072 |
| March 07, 2024 | 2.011 |
| March 06, 2024 | 2.006 |
| March 05, 2024 | 1.990 |
| March 04, 2024 | 2.093 |
| March 01, 2024 | 2.014 |
| February 29, 2024 | 2.052 |
| February 28, 2024 | 2.011 |
| February 27, 2024 | 2.042 |
| February 26, 2024 | 1.963 |
| February 23, 2024 | 2.011 |
| February 22, 2024 | 1.974 |
| February 21, 2024 | 1.806 |
| February 20, 2024 | 1.989 |
| February 16, 2024 | 2.134 |
| February 15, 2024 | 2.175 |
| February 14, 2024 | 1.939 |
| February 13, 2024 | 1.724 |
| February 12, 2024 | 1.744 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.039
Minimum
Dec 20 2023
38.44
Maximum
Jun 25 2020
8.804
Average
5.646
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.730 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7065 |
| Theriva Biologics Inc | 0.1707 |
| Oragenics Inc | 3.129 |
Price to Book Value Related Metrics
| PS Ratio | 2.644 |
| Price | 0.855 |
| Earnings Yield | -146.2% |
| Market Cap | 26.54M |